Gavin Choy

915 total citations
41 papers, 391 citations indexed

About

Gavin Choy is a scholar working on Oncology, Molecular Biology and Pulmonary and Respiratory Medicine. According to data from OpenAlex, Gavin Choy has authored 41 papers receiving a total of 391 indexed citations (citations by other indexed papers that have themselves been cited), including 18 papers in Oncology, 16 papers in Molecular Biology and 13 papers in Pulmonary and Respiratory Medicine. Recurrent topics in Gavin Choy's work include Lung Cancer Treatments and Mutations (8 papers), Cancer Treatment and Pharmacology (8 papers) and Epigenetics and DNA Methylation (7 papers). Gavin Choy is often cited by papers focused on Lung Cancer Treatments and Mutations (8 papers), Cancer Treatment and Pharmacology (8 papers) and Epigenetics and DNA Methylation (7 papers). Gavin Choy collaborates with scholars based in United States, Canada and United Kingdom. Gavin Choy's co-authors include Pietro Taverna, Mohammad Azab, Sanjeev Redkar, Laurence Z. Rubenstein, Elizabeth A. Griffiths, Adam R. Karpf, John F. Lyons, Anthony W. Tolcher, Aram Oganesian and Kenneth P. Nephew and has published in prestigious journals such as Journal of Clinical Oncology, Blood and Cancer Research.

In The Last Decade

Gavin Choy

39 papers receiving 374 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Gavin Choy United States 10 208 81 65 58 54 41 391
Sanders Chang United States 11 138 0.7× 114 1.4× 76 1.2× 62 1.1× 74 1.4× 25 417
Smita Kayal India 11 65 0.3× 197 2.4× 20 0.3× 31 0.5× 47 0.9× 79 386
Elena Tenti Italy 7 108 0.5× 173 2.1× 56 0.9× 48 0.8× 61 1.1× 37 390
Vito Michele Garrisi Italy 11 95 0.5× 79 1.0× 20 0.3× 18 0.3× 25 0.5× 16 257
Luis Miguel Juárez‐Salcedo Spain 7 86 0.4× 102 1.3× 31 0.5× 12 0.2× 59 1.1× 24 325
Sarah S. Burns United States 15 167 0.8× 85 1.0× 128 2.0× 9 0.2× 36 0.7× 28 468
Nathalie Letarte Canada 10 137 0.7× 221 2.7× 33 0.5× 8 0.1× 141 2.6× 26 477
Hyunho Kim South Korea 10 90 0.4× 163 2.0× 33 0.5× 29 0.5× 100 1.9× 37 326
Erin Maynard United States 12 137 0.7× 192 2.4× 97 1.5× 241 4.2× 76 1.4× 41 553

Countries citing papers authored by Gavin Choy

Since Specialization
Citations

This map shows the geographic impact of Gavin Choy's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Gavin Choy with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Gavin Choy more than expected).

Fields of papers citing papers by Gavin Choy

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Gavin Choy. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Gavin Choy. The network helps show where Gavin Choy may publish in the future.

Co-authorship network of co-authors of Gavin Choy

This figure shows the co-authorship network connecting the top 25 collaborators of Gavin Choy. A scholar is included among the top collaborators of Gavin Choy based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Gavin Choy. Gavin Choy is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Hale, Diane F., Timothy J. Vreeland, Gavin Choy, et al.. (2016). Interim safety analysis of a phase II trial combining trastuzumab and NeuVax, a HER2-targeted peptide vaccine, to prevent breast cancer recurrence in HER2 low expression. Annals of Oncology. 27. vi366–vi366. 1 indexed citations
2.
Fang, Fang, Joanne M. Munck, Jessica Tang, et al.. (2014). The Novel, Small-Molecule DNA Methylation Inhibitor SGI-110 as an Ovarian Cancer Chemosensitizer. Clinical Cancer Research. 20(24). 6504–6516. 81 indexed citations
3.
Mita, Monica, Michael S. Gordon, Lee S. Rosen, et al.. (2014). Phase 1B study of amuvatinib in combination with five standard cancer therapies in adults with advanced solid tumors. Cancer Chemotherapy and Pharmacology. 74(1). 195–204. 25 indexed citations
4.
Griffiths, Elizabeth A., Gavin Choy, Sanjeev Redkar, et al.. (2013). SGI-110. DNA methyltransferase inhibitor, Oncolytic. Drugs of the Future. 38(8). 535–535. 2 indexed citations
5.
Maio, Michele, Gavin Choy, Alessia Covre, et al.. (2013). Immunomodulatory Activity of SGI-110, a Second Generation Hypomethylating Agent. Annals of Oncology. 24. i7–i7. 1 indexed citations
6.
Mahadevan, Daruka, Geoffrey I. Shapiro, Sandra Kurtin, et al.. (2013). Activity of AT13387, a novel, non-ansamycin inhibitor of heat shock protein 90, against gastrointestinal stromal tumors (GIST).. Journal of Clinical Oncology. 31(4_suppl). 105–105. 6 indexed citations
7.
Choy, Gavin, et al.. (2012). Safety, tolerability, and pharmacokinetics of amuvatinib from three phase 1 clinical studies in healthy volunteers. Cancer Chemotherapy and Pharmacology. 70(1). 183–190. 6 indexed citations
8.
Tibes, Raoul, Gavin Choy, Sanjeev Redkar, et al.. (2012). A phase I, first-in-human dose-escalation study of amuvatinib, a multi-targeted tyrosine kinase inhibitor, in patients with advanced solid tumors. Cancer Chemotherapy and Pharmacology. 71(2). 463–471. 25 indexed citations
9.
Mahalingam, Devalingam, Claudia M. Espitia, Ernest Medina, et al.. (2011). Targeting PIM kinase enhances the activity of sunitinib in renal cell carcinoma. British Journal of Cancer. 105(10). 1563–1573. 21 indexed citations
10.
Baxter, Patricia, Patrick A. Thompson, Brian Gibson, et al.. (2010). Plasma and cerebrospinal fluid pharmacokinetics of MP470 in non-human primates. Cancer Chemotherapy and Pharmacology. 67(4). 809–812. 5 indexed citations
11.
12.
13.
Tang, Chunlin, et al.. (2009). Abstract B209: A self-emulsifying lipid suspension formulation enhances oral bioavailability of MP-470 in a randomized two-way crossover study in healthy male subjects. Molecular Cancer Therapeutics. 8(12_Supplement). B209–B209. 2 indexed citations
14.
15.
Batist, Gerald, John Sarantopoulos, Kamalesh K. Sankhala, et al.. (2007). A phase I and pharmacokinetic (PK) study of vinorelbine liposomes injection in patients with advanced solid tumors, non-Hodgkin’s lymphoma, and Hodgkin’s disease. Molecular Cancer Therapeutics. 6. 1 indexed citations
16.
Deitcher, Steven R., Pieter R. Cullis, May Q. Wong, & Gavin Choy. (2007). Vinorelbine liposomes injection results in greater tumor drug exposure compared to conventional vinorelbine in tumor-bearing nude mice. Molecular Cancer Therapeutics. 6. 3 indexed citations
17.
Wong, May Q., Hagop Kantarjian, Frederick Appelbaum, et al.. (2007). Vincristine sulfate liposomes injection concentrates vincristine in tumor tissue and bone marrow of tumor-bearing mice. 6. 1 indexed citations
18.
Giles, Francis J., et al.. (2006). A Phase I Study of Talvesta® (Talotrexin) in Relapsed or Refractory Leukemia or Myelodysplastic Syndrome.. Blood. 108(11). 1968–1968. 8 indexed citations
19.
Choy, Gavin. (1998). A review of respiratory syncytial virus infection in infants and children. Home Care Provider. 3(6). 306–311. 3 indexed citations
20.
Rubenstein, Laurence Z., et al.. (1997). The Benefits of In‐Home Pharmacy Evaluation for Older Persons. Journal of the American Geriatrics Society. 45(2). 211–214. 42 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Sanders Chang Breakdown of academic impact, for papers by Smita Kayal Breakdown of academic impact, for papers by Elena Tenti Breakdown of academic impact, for papers by Vito Michele Garrisi Breakdown of academic impact, for papers by Luis Miguel Juárez‐Salcedo Breakdown of academic impact, for papers by Sarah S. Burns Breakdown of academic impact, for papers by Nathalie Letarte Breakdown of academic impact, for papers by Hyunho Kim Breakdown of academic impact, for papers by Erin Maynard
Rankless by CCL
2026